Point72 Middle East Fze Illumina, Inc. Call Options Transaction History

Point72 Middle East Fze

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$92.79 - $142.53 $231,975 - $356,325	-2,500 Reduced 83.33%	500 $69,000
Q3 2023 Nov 14, 2023	BUY	$128.91 - $192.44 $141,801 - $211,684	1,100 Added 57.89%	3,000 $411,000
Q2 2023 Aug 14, 2023	SELL	$183.43 - $232.67 $770,406 - $977,214	-4,200 Reduced 68.85%	1,900 $356,000
Q1 2023 May 15, 2023	BUY	$193.75 - $232.55 $930,000 - $1.12 Million	4,800 Added 369.23%	6,100 $1.42 Million
Q4 2022 Feb 14, 2023	BUY	$187.24 - $242.74 $243,412 - $315,562	1,300 New	1,300 $0

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.